Functionalized Low-Density Lipoprotein Nanoparticles for in Vivo Enhancement of Atherosclerosis on Magnetic Resonance Images
Authors:
- Hui QiaoHQHui Qiao
- Ting LiuTLTing Liu
- Takashi IshikawaTITakashi Ishikawa
- Hualei ZhangHZHualei Zhang
- Miao WangMWMiao Wang
- Emanuela RicciottiEREmanuela Ricciotti
- Garret A. FitzGeraldGFGarret A. FitzGerald
- Rong ZhouRZRong Zhou
- Yoko YamakoshiYYYoko Yamakoshi
- 1 November 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 23 (11) , 2313-2319
Abstract
To allow visualization of macrophage-rich and miniature-sized atheromas by magnetic resonance (MR) imaging, we have converted low-density lipoprotein (LDL) into MR-active nanoparticles via the intercalation of a 1,4,7,10-tetraazacyclodecane-1,4,7-triacetic acid (DO3A) derivative and the subsequent coordination reaction with Gd3+. After careful removal of nonchelated Gd3+, an MR-active LDL (Gd3+-LDL) with a remarkably high payload of Gd3+ (in excess of 200 Gd3+ atoms per particle) and a high relaxivity (r1 = 20.1 s–1 mM–1 per Gd3+ or 4040 s–1 mM–1 per LDL) was obtained. Dynamic light-scattering photon correlation spectroscopy (DLS) and cryo transmission electron microscope (cryoTEM) images showed that Gd3+-LDL particles did not aggregate and remained of a similar size (25–30 nm) to native LDL. Intravenous injection of Gd3+-LDL into an atherosclerotic mouse model (ApoE–/–) resulted in an extremely high enhancement of the atheroma-bearing aortic walls at 48 h after injection. Free Gd3+ dissociation from Gd3+-LDL was not detected over the imaging time window (96 h). Because autologous LDL can be isolated, modified, and returned to the same patient, our results suggest that MR-active LDL can potentially be used as a noninfectious and nonimmunogenic imaging probe for the enhancement of atheroplaques presumably via the uptake into macrophages inside the plaque.Keywords
This publication has 43 references indexed in Scilit:
- Annexin A5-Functionalized Bimodal Nanoparticles for MRI and Fluorescence Imaging of Atherosclerotic PlaquesBioconjugate Chemistry, 2010
- Hybrid PET-optical imaging using targeted probesProceedings of the National Academy of Sciences, 2010
- Spatiotemporal controlled delivery of nanoparticles to injured vasculatureProceedings of the National Academy of Sciences, 2010
- Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaqueMagnetic Resonance in Medicine, 2009
- Targeting atherosclerosis by using modular, multifunctional micellesProceedings of the National Academy of Sciences, 2009
- Nanoparticles for Optical Molecular Imaging of AtherosclerosisSmall, 2009
- A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptidesJournal of Controlled Release, 2008
- Imaging of atherosclerotic cardiovascular diseaseNature, 2008
- Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probesJournal of Magnetic Resonance Imaging, 2007
- Novel Paramagnetic Macromolecular Complexes Derived from the Linkage of a Macrocyclic Gd(III) Complex to Polyamino Acids through a Squaric Acid MoietyBioconjugate Chemistry, 1999